Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Lieberman

Showing results (151-160 of 154) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 154 results.
Pigment Cell & Melanoma Research|August 9, 2017
Feasibility of monitoring advanced melanoma patients using cell-free DNA from plasmaTara C Gangadhar, Samantha L Savitch, Stephanie S Yee, et al.
JAMA Oncology|October 17, 2018
Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung CancerCharu Aggarwal, Jeffrey C Thompson, Taylor A Black, et al.
Nature Medicine|January 24, 2024
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapyGuido Ghilardi, Joseph A Fraietta, James N Gerson, et al.
The Journal of Clinical Investigation|April 3, 2025
ATM-dependent DNA damage response constrains cell growth and drives clonal hematopoiesis in telomere biology disordersChristopher M Sande, Stone Chen, Dana V Mitchell, et al.
Pageof 16

Showing results (151-160 of 154) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 154 results.
Pigment Cell & Melanoma Research|August 9, 2017
Feasibility of monitoring advanced melanoma patients using cell-free DNA from plasmaTara C Gangadhar, Samantha L Savitch, Stephanie S Yee, et al.
JAMA Oncology|October 17, 2018
Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung CancerCharu Aggarwal, Jeffrey C Thompson, Taylor A Black, et al.
Nature Medicine|January 24, 2024
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapyGuido Ghilardi, Joseph A Fraietta, James N Gerson, et al.
The Journal of Clinical Investigation|April 3, 2025
ATM-dependent DNA damage response constrains cell growth and drives clonal hematopoiesis in telomere biology disordersChristopher M Sande, Stone Chen, Dana V Mitchell, et al.
Pageof 16